- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
On May 19, 2011, the American Bar Association (ABA) Section of Environment, Energy, and Resources (SEER) Pesticides, Chemical Regulation, and Right-to-Know Committee will present a half-day webinar program on nano governance. Nanotechnology Industries Association's intrepid leader, Dr. Steffi Friedrichs, is scheduled to present at this important program.
States, federal agencies, and foreign governments are challenged to address the risks and promote the benefits of evolving technologies, including nanotechnology. Companies globally are continuing to harness the properties of nanomaterials for use in products from airplanes to pharmaceuticals and from cosmetics to food packaging.
This program will explore the new and creative applications of existing regulatory tools and governance approaches to address the potential risks of nanotechnologies, implementing new risk assessment approaches to evolving technologies, and maximizing the potential benefits of these materials. Panelists will report on new and emerging federal, State, and international nanomaterials regulations and governance strategies. Representatives from the U.S. Environmental Protection Agency, Consumer Products Safety Commission, and Australian National Industrial Chemicals Notification and Assessment Scheme (NICNAS) will share insights about their nanoscale chemical programs. Representatives from industry and the Environmental Defense Fund will also present.
Attendees will gain insight into potential public health and environmental impacts and the approaches various government agencies and industrial stakeholders are pursuing to address these issues while also promoting nanotechnology. The program is open to attorneys and other professionals with chemical regulatory compliance practices.
The educational objectives of the program are:
Objective 1: Develop familiarity with new and emerging federal, State, and international nanomaterials regulations and governance strategies.
Objective 2: Understand Potential Public Health and Environmental Impacts and the approaches various government agencies are pursuing to promote nanotechnology while also addressing potential public health and environmental risks.
Objective 3: Appreciate complexities of addressing potential risks with existing governance tools and strategies while also embracing new approaches to accommodate evolving technologies.
About Bergeson & Campbell, P.C.
Bergeson & Campbell, P.C. is an AV-rated (highest ranking) Washington, D.C. law firm focusing on conventional and nanoscale, industrial, agricultural, and specialty chemical product regulation and approval matters, including TSCA matters, FIFRA/FQPA matters, FDA medical device and product approval, registration and data compensation arbitrations, chemical product litigation, and associated business counseling and litigation issues. Bergeson & Campbell's clients are involved in many businesses, including conventional and nanoscale, basic, specialty, and agricultural and antimicrobial chemicals; biotechnology, nanotechnology, and emerging transformative technologies; pharmaceuticals, medical devices, and diagnostic products; fibers; paints and coatings; printing and publishing; and plastic products.
For more information, please click here
Lynn L. Bergeson
1203 Nineteenth Street, N.W., Suite 300
Washington, District of Columbia 20036 USA
Copyright © Bergeson & Campbell, P.C.If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Physicists solve quantum tunneling mystery: ANU media release: An international team of scientists studying ultrafast physics have solved a mystery of quantum mechanics, and found that quantum tunneling is an instantaneous process May 27th, 2015
Nanotechnology identifies brain tumor types through MRI 'virtual biopsy' in animal studies: If results are confirmed in humans, tumor cells could someday be diagnosed by MRI imaging and treated with tumor-specific IV injections; new NIH grant will fund future study May 27th, 2015
One step closer to a single-molecule device: Columbia Engineering researchers first to create a single-molecule diode -- the ultimate in miniaturization for electronic devices -- with potential for real-world applications May 25th, 2015